[New possibilities in the therapy of EPH-gestosis].
D000328:Adult; D000818:Animals; D001002:Anuria / Q000209:etiology; D001778:Blood Coagulation Disorders / Q000209:etiology; D001792:Blood Platelets / Q000378:metabolism; D004232:Diuretics / Q000627:therapeutic use; D004461:Eclampsia / Q000188:drug therapy; D004487:Edema / Q000209:etiology; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000209:etiology; D008833:Microcirculation / Q000187:drug effects; D011225:Pre-Eclampsia / Q000150:complications / Q000188:drug therapy*; D011247:Pregnancy; D011507:Proteinuria / Q000209:etiology; D011817:Rabbits
D004232:Diuretics; D005340:Fibrinogen; D006493:Heparin
Neue Gesichtspunkte zur Therapie der EPH-Gestose.